Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial
Authors:
- 22 October 2021
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (6) , 102319
Abstract
No abstract availableKeywords
Funding Information
- Hamadan University of Medical Sciences
This publication has 25 references indexed in Scilit:
- Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear ExportCell Reports, 2019
- Naproxen attenuates osteoarthritis progression through inhibiting the expression of prostaglandinl‐endoperoxide synthase 1Journal of Cellular Physiology, 2018
- Marine OMEGA-3 fatty acids in the prevention of cardiovascular diseaseFitoterapia, 2017
- Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertensionBMC Cardiovascular Disorders, 2012
- Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A ReviewAnti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2012
- Coxibs and Cardiovascular DiseaseNew England Journal of Medicine, 2004
- Diet and Overall Survival in a Cohort of Very Elderly PeopleEpidemiology, 2000
- Hematologic and Body Fluid Changes during Simulated High Altitude Exposure in Naproxen-Treated Rats.The Japanese Journal of Physiology, 1996
- Combined Antiviral and Antimediator Treatment of Rhinovirus ColdsThe Journal of Infectious Diseases, 1992
- Effects of Naproxen on Experimental Rhinovirus ColdsAnnals of Internal Medicine, 1992